Showing results (1571-1580 of 1,994) with videos related to

Sort By:
Pageof 200
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancerLorenzo Melchor, Emiliano Honrado, Jia Huang, et al.
Molecular and Cellular Biology|September 11, 2013
The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanomaEric K Lee, Zhaorui Lian, Kurt D'Andrea, et al.
Stem Cell Reports|April 16, 2017
High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem CellsMatteo D'Antonio, Grace Woodruff, Jason L Nathanson, et al.
Journal of Cutaneous Pathology|December 16, 2018
NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenibVishwas Parekh, Joseph Sobanko, Christopher J Miller, et al.
The Breast Journal|April 11, 2012
The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapyAlfred I Neugut, Grace Clarke Hillyer, Lawrence H Kushi, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|October 15, 2010
Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative projectRoger S McIntyre, Sidney H Kennedy, Joanna K Soczynska, et al.
Nature Communications|January 22, 2015
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomasLauren Fishbein, Sanika Khare, Bradley Wubbenhorst, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2020
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reductionNeda Stjepanovic, Guillermo Villacampa, Kevin T Nead, et al.
The American Journal of Pathology|April 25, 2009
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytesHong Yu, Ronan McDaid, John Lee, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational studyFrederik Persson, Johan Bodegard, Jorma T Lahtela, et al.
Pageof 200